Niagen Bioscience, Inc. (NAGE)
2.47
-0.04
(-1.59%)
USD |
NASDAQ |
Oct 21, 16:00
2.455
-0.02
(-0.61%)
After-Hours: 20:00
Niagen Bioscience Enterprise Value : 130.49M for Oct. 21, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 21, 2026 | 130.49M |
| October 20, 2026 | 133.65M |
| October 19, 2026 | 132.86M |
| October 16, 2026 | 132.07M |
| October 15, 2026 | 139.17M |
| October 14, 2026 | 135.23M |
| October 13, 2026 | 139.17M |
| October 12, 2026 | 143.12M |
| October 09, 2026 | 147.85M |
| October 08, 2026 | 145.48M |
| October 07, 2026 | 150.22M |
| October 06, 2026 | 147.85M |
| October 05, 2026 | 147.06M |
| October 02, 2026 | 155.74M |
| October 01, 2026 | 147.06M |
| September 30, 2026 | 166.00M |
| September 29, 2026 | 168.37M |
| September 28, 2026 | 170.73M |
| September 25, 2026 | 176.26M |
| September 24, 2026 | 173.10M |
| September 23, 2026 | 172.31M |
| September 22, 2026 | 179.41M |
| September 21, 2026 | 175.47M |
| September 18, 2026 | 171.52M |
| September 17, 2026 | 171.52M |
| Date | Value |
|---|---|
| September 16, 2026 | 172.31M |
| September 15, 2026 | 172.31M |
| September 14, 2026 | 175.47M |
| September 11, 2026 | 175.47M |
| September 10, 2026 | 175.07M |
| September 09, 2026 | 176.26M |
| September 08, 2026 | 180.20M |
| September 04, 2026 | 185.73M |
| September 03, 2026 | 180.99M |
| September 02, 2026 | 185.73M |
| September 01, 2026 | 182.57M |
| August 31, 2026 | 182.57M |
| August 28, 2026 | 195.20M |
| August 27, 2026 | 188.88M |
| August 26, 2026 | 195.99M |
| August 25, 2026 | 193.62M |
| August 24, 2026 | 188.88M |
| August 21, 2026 | 188.88M |
| August 20, 2026 | 184.15M |
| August 19, 2026 | 185.73M |
| August 18, 2026 | 177.05M |
| August 17, 2026 | 175.47M |
| August 14, 2026 | 173.89M |
| August 13, 2026 | 176.26M |
| August 12, 2026 | 177.05M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Cyanotech Corp. | 14.48M |
| Mannatech, Inc. | 16.89M |
| Natural Alternatives International, Inc. | 49.96M |
| USANA Health Sciences, Inc. | 138.65M |
| Nature's Sunshine Products, Inc. | 154.87M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 0.963M |
| Revenue (Quarterly) | 29.78M |
| Total Expenses (Quarterly) | 28.82M |
| EPS Diluted (Quarterly) | 0.0117 |
| Gross Profit Margin (Quarterly) | 64.84% |
| Profit Margin (Quarterly) | 3.23% |
| Earnings Yield | 7.62% |
| Operating Earnings Yield | 4.13% |
| Normalized Earnings Yield | 7.619 |